CNTG — Centogene NV Income Statement
0.000.00%
Last trade - 00:00
- $18.11m
- $67.55m
- €47.47m
- 27
- 57
- 24
- 29
2018 December 31st | 2019 December 31st | R2020 December 31st | R2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 20-F | 20-F | 20-F | 20-F |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 40.5 | 48.8 | 38.5 | 42.2 | 47.5 |
Cost of Revenue | |||||
Gross Profit | 20.5 | 22.8 | 7.87 | 14.6 | 19.9 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 51.1 | 67.5 | 96.9 | 98.9 | 84.2 |
Operating Profit | -10.6 | -18.7 | -58.4 | -56.6 | -36.8 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -11.6 | -20.7 | -59.8 | -57.4 | -38.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | -11.3 | -20.9 | -60 | -57.4 | -38.7 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -11.3 | -20.9 | -22 | -46.2 | -31.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -11.3 | -20.9 | -22 | -46.2 | -31.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.571 | -1.03 | -2.61 | -2.5 | -1.44 |
Dividends per Share |